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DDiscussion
Dr Marc Moon (St Louis, Mo). The on-pump versus off-pump
debate has been going on for more than a decade, and we really
aren’t reaching any resolution anytime soon. Although your study
demonstrated no difference in the incidence of renal dysfunction,
there was a study yesterday [Presented by Lemma M, et al.
On-pump vs off-pump coronary artery bypass surgery in high-
risk patients: operative results of a prospective randomized trial
(on-off study).] that showed the opposite result, and I think most
of the studies have been one way or the other and haven’t come
to a strong conclusion.
I am always impressed when I show up in the intensive care unit
the day after surgery and see 2 patients in 2 beds next to each other,
and you can’t tell which one had off-pump and which one had on-
pump surgery. The only consistent finding in most of the studies
has been a decrease in the transfusion requirements in off-pump
surgery, although in a center that uses strict blood conservation
techniques, the difference may be fairly minimal.
I would like to ask you a couple of questions about your study.
One is this matching technique that you used. You didn’t really
give us much detail on that. That is a bit usual; it wasn’t a propen-
sity match. Maybe you can get a bit into the statistical analysis of
that.
Second, your OPCAB cases were substantially sicker, it ap-
peared, than the on-pump CABG cases. Do you think the matching
or the multivariate analysis you used can really tease out robustly
the differences that may be intrinsic in those 2 different groups of
patients?
On thebasis of yourfindings,what techniquedoes your center rec-
ommend for these patients undergoing off-pump versus on-pump
surgery, and does it depend on the subgroup of patientswho is under-
going operation or is it just surgeon dependent on what he or she is
most comfortable which, which is what my feelings are?
Dr Elmistekawy. In response to your first question, we used
a bias-corrected nearest neighbor matching estimation for averageThe Journal of Thoracic and Ctreatment. This technique has been mostly used in economics, and
the 5309 patients undergoing on-pump CABG were matched clos-
est to matches in the opposite treatment group, namely, the 550 pa-
tients undergoing OPCAB, by allowing each observation to be
used as a match more than once if necessary, with the order of
matching being irrelevant; this, therefore, provided an estimate
of the counterfactual treatment outcome. It is important to note
that some variables were specified in the model to be matched ex-
actly, such as gender, cerebrovascular disease, and left ventricular
grade, whereas others, such as age, body mass index, and preoper-
ative creatinine, were matched to their nearest neighbor. We think
that is used in economics with good validity, and it can also give us
a good idea about the average treatment with bias correction.
For your second question, yes, this study included sicker patients
undergoing OPCAB, and these sicker patients may have had a dif-
ferent biological response to perioperative stress and bemore prone
to have renal dysfunction after surgery. Butwe did both amultivari-
able regression analysis and thismatching analysis, trying to get out
all of the confounders, by including all of the major factors that can
affect the renal outcome in those patients.
In our center, the choice of on-pump versus off-pump technique
is influenced by many factors: number one, patient characteristics,
such as the presence of ascending aortic disease and coronary anat-
omy; number two, patient preference, such as if the patient asks for
OPCAB, or the cardiologist referral, which also is a factor in the
selection of on-pump CABG versus OPCAB.
Dr Moon. We can safely conclude that these days the most
appropriate thing is for the surgeon to do the operation he or she
is most comfortable with.
Dr Lokeswara Sajja (Hyderabad, India). I congratulate
Dr Elmistekawy for a good presentation, and I have a comment
to make and a couple of questions to ask. We are one of the earlier
groups to conduct a randomized study on the effect of off-pump and
on-pump techniques in patients with preoperative nondialysis-de-
pendent renal insufficiency undergoing CABG, and our study
proved that the off-pump technique is renoprotective in patients
with nondialysis-dependent renal insufficiency. As we all know,
approximately 15% to 20% of the patients undergoing CABG
have occult renal dysfunction, meaning they have normal serum
creatinine levels (ie, 1.3 mg/dL) in association with decreased
glomerular filtration rate (ie,<60 mL/min/1.73 m2 body area).
In this study, as you have presented, there is a statistically
significant difference in the preoperative serum creatinine levels
between the off-pump and on-pump groups. In the OPCAB group,
the mean serum creatinine level is 1.3 mg/dL, and in the on-pump
CABGgroup, the serum creatinine level is 1.0mg/dL. Even a small
increase in the preoperative serum creatinine also has a deleterious
effect on the postoperative incidence of acute kidney injury.
My question to you is, did you routinely estimate the glomerular
filtration rate in these patients? The other question is, what
percentage of these patients received aprotinin during their perio-
perative period to control bleeding?
Dr Elmistekawy. I am sorry, I didn’t get your questions.
Dr Sajja. Did you estimate creatinine clearance in these
patients? If so, what percentage of the patients in each group
had occult renal disease?
Dr Elmistekawy. We did creatinine clearance estimation for
the purpose of this study, but otherwise it wasn’t routinely done.ardiovascular Surgery c Volume 143, Number 1 91
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DDr Sajja. Did more patients receive aprotinin in the OPCAB
group?
Dr Elmistekawy. I am sorry, I didn’t get the question.
Dr Sajja. Is there any difference in the use of aprotinin between
the 2 groups?
Dr Elmistekawy. Aprotinin.
Dr Sajja. Use of aprotinin between the 2 groups?
Dr Elmistekawy. We didn’t examine this.
Dr Marc Ruel (Ottawa, Ontario, Canada). Perhaps I could in-
tervene. My name is Marc Ruel; I am the senior author of this
study. Aprotinin was not used at all in this series except for excep-
tional cases, for instance, patients receiving clopidogrel during
emergency cases, in the old times.
I would like to comment on the findings and respond to some of
the excellent questions that have been raised. First, I am an off-
pump enthusiast and believer. When we started this study, we
thought we would actually prove once and for all, in a series
with large numbers and good outcomes, that OPCAB is better
than CABG on the kidney. Actually, we were surprised to find
the complete reverse, in that there was no outcome difference,
not only at the univariate level but also at 2 levels of multivariable
analysis, even when accounting for preoperative differences in
renal function and for comorbidities.
So from this we can think, why do we have those findings?
I think Elsayed alluded to the possible institutional or technical
factors that may have caused this lack of difference, and one of
those factors may be the extra fluid load that patients undergoing
CABG receive. A patient undergoing CABG typically comes out
of the operating room with 4 or 5 extra kilos of fluid, and that
may in itself be renal protective. On the other hand, we don’t
have this extra fluid load in OPCAB cases. In addition, OPCAB
cases have more ups and downs in terms of their cardiac output
during the procedure. They may have short periods of inotrope
use, especially when grafting the lateral wall.92 The Journal of Thoracic and Cardiovascular SurgeFurthermore, maybe one of the reasons we don’t see a difference
in this study while smaller studies have shown opposite results is
that the event rates were overall very low. The results of on-
pump CABG and OPCAB in this study, even if when including
all emergencies, and patients in cardiogenic shock, and patients
coming from the catheter laboratory, were very good. So these re-
sults clearly show that the perfusion teamdoes an excellent jobwith
those usual, short 1-hour cardiopulmonary bypass time periods
needed to do 3 or 4 grafts. Well, with those as a typical, routine
case, it is hard to show a difference between off-pump and on-
pump on the renal outcomes. With this, I would like to acknowl-
edge the excellent questions and comments that have been raised,
and thank the Association for the honor of presenting these data.
Dr Massimo Lemma (Milano, Italy). One comment and one
question. The comment is that we had a completely different expe-
rience. Yesterday I presented the primary end point of the ON-OFF
study, where we compared 30-day outcomes of high-risk patients
with a euroSCORE greater than 6 after on-pump CABG or
OPCAB. In our study, the intention-to-treat analysis showed that
there is an advantage for these patients in terms of renal failure,
even if not statistically significant, but it became statistically signif-
icant after on-treatment analysis, that is, after consideration of
crossovers.
The question is related to what you do to maintain hemody-
namic stability during the operation. Could you precisely tell us
the anesthetic and surgical management of the patient during
OPCAB to maintain hemodynamic stability and if you check the
cardiac output during the operation?
Dr Elmistekawy. You are right, during exposure, especially
of the lateral wall, there is a period of low cardiac output or
hypoperfusion, and we optimize this by using vasoactive drugs
(eg, norepinephrine) and volume loading, with interruption of
the procedure until the blood pressure and the cardiac output
are optimized.ry c January 2012
